Global Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.

Polio Vaccine segment by Company

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Polio Vaccine segment by Type

Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Polio Vaccine segment by Application

Public
Private
Polio Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Polio Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Polio Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Polio Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Polio Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Polio Vaccine Market Dynamics
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 Polio Vaccine Market by Manufacturers
3.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Polio Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Polio Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Polio Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Polio Vaccine Manufacturers, Product Type & Application
3.7 Global Polio Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Polio Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier 3
4 Polio Vaccine Market by Type
4.1 Polio Vaccine Type Introduction
4.1.1 Inactivated Polio Vaccine (IPV)
4.1.2 Oral Polio Vaccine (OPV)
4.2 Global Polio Vaccine Sales by Type
4.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Polio Vaccine Sales by Type (2019-2030)
4.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Polio Vaccine Revenue by Type
4.3.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Polio Vaccine Revenue by Type (2019-2030)
4.3.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5 Polio Vaccine Market by Application
5.1 Polio Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Sales by Application
5.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Application (2019-2030)
5.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Polio Vaccine Revenue by Application
5.3.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Polio Vaccine Revenue by Application (2019-2030)
5.3.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6 Global Polio Vaccine Sales by Region
6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Polio Vaccine Sales by Region (2019-2030)
6.2.1 Global Polio Vaccine Sales by Region (2019-2024)
6.2.2 Global Polio Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Polio Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Polio Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Polio Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Polio Vaccine Revenue by Region
7.1 Global Polio Vaccine Revenue by Region
7.1.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Polio Vaccine Revenue by Region (2019-2024)
7.1.3 Global Polio Vaccine Revenue by Region (2025-2030)
7.1.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Polio Vaccine Revenue (2019-2030)
7.2.2 North America Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Polio Vaccine Revenue (2019-2030)
7.3.2 Europe Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Polio Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Polio Vaccine Revenue (2019-2030)
7.5.2 LAMEA Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Polio Vaccine Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Polio Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Bibcol
8.3.1 Bibcol Comapny Information
8.3.2 Bibcol Business Overview
8.3.3 Bibcol Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Bibcol Polio Vaccine Product Portfolio
8.3.5 Bibcol Recent Developments
8.4 Serum Institute
8.4.1 Serum Institute Comapny Information
8.4.2 Serum Institute Business Overview
8.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Serum Institute Polio Vaccine Product Portfolio
8.4.5 Serum Institute Recent Developments
8.5 Tiantan Biological
8.5.1 Tiantan Biological Comapny Information
8.5.2 Tiantan Biological Business Overview
8.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
8.5.5 Tiantan Biological Recent Developments
8.6 IMBCA
8.6.1 IMBCA Comapny Information
8.6.2 IMBCA Business Overview
8.6.3 IMBCA Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 IMBCA Polio Vaccine Product Portfolio
8.6.5 IMBCA Recent Developments
8.7 Panacea Biotec Ltd
8.7.1 Panacea Biotec Ltd Comapny Information
8.7.2 Panacea Biotec Ltd Business Overview
8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
8.7.5 Panacea Biotec Ltd Recent Developments
8.8 Bio-Med
8.8.1 Bio-Med Comapny Information
8.8.2 Bio-Med Business Overview
8.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Med Polio Vaccine Product Portfolio
8.8.5 Bio-Med Recent Developments
8.9 Halfkin Bio-Pharmaceuticals
8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Polio Vaccine Value Chain Analysis
9.1.1 Polio Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Polio Vaccine Production Mode & Process
9.2 Polio Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Polio Vaccine Distributors
9.2.3 Polio Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings